Drug Profile
Camptothecin TCS
Latest Information Update: 29 Dec 2021
Price :
$50
*
At a glance
- Originator Inex Pharmaceuticals Corporation
- Class Antineoplastics; Camptothecins; Drug conjugates; Small molecules
- Mechanism of Action DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 02 May 2003 Discontinued - Preclinical for Cancer in Canada (unspecified route)
- 31 May 2001 Preclinical trials in Cancer in Canada (unspecified route)